Luckwel Pharmaceuticals Inc.
company.status.inactiveCIK 1567098fmd_02PNVQGM04VCKCHQ3QNCHMHJJAManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Mar 01, 2013 to Mar 31, 2021, 35 periods
Latest annual · FY2021
Millions- Net income
- (0)
Latest quarter · Q4 FY2021
Millions- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2016 to FY2021
- n/m
Luckwel Pharmaceuticals Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Net income | -$436,013 | -$536,432 | 10-K 2021-09-09 · proof | |
| Cash from operating activities | -$197,975 | -$318,210 | 10-K 2021-09-09 · proof | |
| Total assets | $46,681 | $17,213 | +171.2% | 10-K 2021-09-09 · proof |
| Total liabilities | $490,949 | $1.3 million | -63.5% | 10-K 2021-09-09 · proof |
| Cash and cash equivalents | $2,044 | $44 | +4,545.5% | 10-K 2021-09-09 · proof |
- What was Luckwel Pharmaceuticals Inc.'s net income in fiscal 2021?
- Luckwel Pharmaceuticals Inc. reported net income of -$436,013 for fiscal 2021 (the year ended Mar 31, 2021), against -$536,432 the year before. Source: the 10-K filed with the SEC on Sep 9, 2021. SEC
- What was Luckwel Pharmaceuticals Inc.'s cash from operating activities in fiscal 2021?
- Luckwel Pharmaceuticals Inc. reported cash from operating activities of -$197,975 for fiscal 2021 (the year ended Mar 31, 2021), against -$318,210 the year before. Source: the 10-K filed with the SEC on Sep 9, 2021. SEC
- What are Luckwel Pharmaceuticals Inc.'s total assets?
- As of Mar 31, 2021, Luckwel Pharmaceuticals Inc. reported total assets of $46,681, against $17,213 a year earlier (+171.2%). Source: the 10-K filed with the SEC on Sep 9, 2021. SEC
- What are Luckwel Pharmaceuticals Inc.'s total liabilities?
- As of Mar 31, 2021, Luckwel Pharmaceuticals Inc. reported total liabilities of $490,949, against $1.3 million a year earlier (-63.5%). Source: the 10-K filed with the SEC on Sep 9, 2021. SEC
- What are Luckwel Pharmaceuticals Inc.'s cash and cash equivalents?
- As of Mar 31, 2021, Luckwel Pharmaceuticals Inc. reported cash and cash equivalents of $2,044, against $44 a year earlier (+4,545.5%). Source: the 10-K filed with the SEC on Sep 9, 2021. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1567098&period_type=annual&limit=5"Information only, not investment advice.